This finding is underlined by the more frequent IL-23p19 positivity in tumours with MMR-deficiency, a subgroup of colorectal cancers known for their abundant CD8+ T-cell counts and favourable survival in affected patients. This evidence concerns the gene CD8A and mismatch repair cancer syndrome 1.